We are live on
!
Find out more
APMC
Alta Partners Management Company Portfolio holdings
AUM
$127M
1-Year Est. Return
230.85%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+230.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$41.6M
AUM Growth
-$160K
(-0.38%)
Cap. Flow
-$537K
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vir Biotechnology
VIR
|
+$42.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$580K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
FG
MWML
DIG
RWIA
AWS
CPX
KCM
EHAM
Alta Partners Management Company's Q2 2025 Portfolio in Review
As of Q2 2025, Alta Partners Management Company held 3 positions worth $41.6M, down 0.38% from $41.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alta Partners Management Company's Q2 2025 filing shows 1 increased and 1 closed positions. The largest sale was Allakos, an estimated $580K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Alta Partners Management Company added most to Vir Biotechnology in Q2 2025, an estimated $42.9K increase.
- Alta Partners Management Company fully exited Allakos in Q2 2025, selling an estimated $580K.
- Alta Partners Management Company's ten largest holdings make up 100% of its $41.6M portfolio in Q2 2025.
- Alta Partners Management Company opened 0 new positions and closed 1 in Q2 2025.
- Alta Partners Management Company's portfolio value fell 0.38% quarter-over-quarter to $41.6M.
Based on Alta Partners Management Company's 13F filing for Q2 2025, filed 14 Aug 2025.